MYO-029

DRUG2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Becker Muscular DystrophyFacioscapulohumeral Muscular DystrophyHealthyLimb-Girdle Muscular Dystrophy

Phase 1

Study Evaluating MYO-029 in Adult Muscular Dystrophy

CompletedNCT00104078

Wyeth is now a wholly owned subsidiary of PfizerBecker Muscular Dystrophy, Facioscapulohumeral Muscular Dystrophy, Limb-Girdle Muscular Dystrophy

Start: 2005-02-28End: 2007-01-31Target: 108Updated: 2007-12-28

Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of MYO-029

CompletedNCT00563810

Wyeth is now a wholly owned subsidiary of PfizerHealthy

Start: 2004-10-31End: 2006-04-30Target: 72Updated: 2007-11-26